We're here to help
Whether you’re a FemTech innovator or you’re working within the health and care system to address health disparities, we can support your mission.
Get in touch with the team to find out more about our work.
Email usAccelerating FemTech: Evaluate
Supporting innovators to make a real impact in women’s health
Accelerating FemTech: Evaluate is a 10 week Innovate UK Biomedical Catalyst Accelerator that supports UK companies with technologies for women’s health that are already developed but are looking to prove their value.
Funded by Innovate UK Biomedical Catalyst and delivered by the Health Innovation Network South London with national partners, it offers tailored support, expert workshops and one-to-one business coaching. The goal is to help companies grow, connect with the right people and plan testing of solutions in real-world healthcare settings, including cost-effectiveness.
This programme is currently closed for applications
Read the Accelerating FemTech Impact Report
Programme overview
In 2025, the Health Innovation Network South London was recommissioned to deliver Accelerating FemTech: Evaluate, one of five thematic Innovate UK Biomedical Catalyst Accelerators. The series of thematic Accelerators expanded on Innovate UK’s longstanding work supporting start-ups, entrepreneurs and spinouts to gain the momentum needed to drive innovation in the healthcare system.
Building on the Accelerating FemTech programme for early-stage companies and recognising the demand for tailored support from innovators at more advanced stages of development, Accelerating FemTech: Evaluate was designed for later-stage innovations for women’s health with a technology readiness level (TRL) 4 or above.
The programme aimed to bridge the gap between visionary women’s health solutions and the complex realities of healthcare markets, enabling growth through tailored support, planning strategic partnerships and refining pathways for real-world evaluation, such as health economic analyses.
"The connections and the understanding practically of partnership with the NHS [was key for me]. I know I needed to understand what these steps look like and make the right connections in order to support this. It has opened so, so many doors for me, so thank you very much.” Mari-Carmen Sanchez-Morris, Founder and CEO, Matresa
Programme impact
Accelerating FemTech: Evaluate was delivered between November 2025 and February 2026, with 10 later-stage FemTech innovations benefitting from a hybrid curriculum of support, delivered in collaboration with a national network of partners.
100%
of participants would repeat the programme
100%
of participants more aware of important considerations for evaluation, with eight establishing partnerships for evaluation during the programme
100%
of participants agreed that the opportunity to network and make new connections had been a highly valuable part of the programme, enabling them to take their innovations forward commercially
Excellent
NPS category, with a score of 100
Read the Accelerating FemTech Impact Report
"Absolutely fantastic. I cannot overstate how incredible this has been and the support has been critical to help my business grow."Laura Corcoran, Founder and CEO, Dignity Care Network
